World Hepatitis Day — July 28, 2016
July 22, 2016
July 28, 2016 marks World Hepatitis Day, established by the World Health Organization to raise awareness and promote understanding of viral hepatitis. A report in this week’s MMWR highlights the need to scale up hepatitis C (HCV) testing among persons at risk, including children born to HCV-infected mothers, and improve surveillance, particularly among women who are pregnant or planning pregnancy.
Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission — United States and Kentucky, 2011–2014
July 22, 2016
Increased rates of hepatitis C virus (HCV) detection (antibody or RNA positivity) were observed among women of childbearing age nationally and for Kentucky during 2011–2014. Increased rates of HCV testing (antibody or RNA) among children aged ≤2 years were also observed nationally and for Kentucky during this timeframe.
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance —The Gonococcal Isolate Surveillance Project,27 Sites, United States, 2014
July 15, 2016
Gonorrhea is the second most commonly reported notifiable disease in the United States. Prevention of sequelae and of transmission to sexual partners relies on prompt detection and effective treatment. However, treatment has been compromised by the absence of routine antimicrobial susceptibility testing in clinical care and evolution of antimicrobial resistance to the antibiotics used to treat gonorrhea. Dual therapy with ceftriaxone plus azithromycin is the only recommended gonorrhea treatment, and the potential threat of cephalosporin-resistant gonorrhea is a cause for concern. This report presents comprehensive surveillance data from the Gonococcal Isolate Surveillance Project and describes gonococcal antimicrobial susceptibility patterns in the United States during 2000–2014. Antimicrobial susceptibility surveillance data can be used to develop national treatment recommendations, set research and prevention priorities, and communicate best treatment practices to health care providers.
CDC’s Response to the 2014–2016 Ebola Epidemic — West Africa and United States
July 8, 2016
This historic 2014-2016 Ebola Epidemic in West Africa required a massive international response by multiple partners to assist the affected countries. This supplement present reports that chronicle major aspects of CDC’s response to the Ebola epidemic.
Recommendations and Reports
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis — United States: A Practical Guide for Health Care and Public Health Professionals
May 13, 2016
Tickborne rickettsial diseases continue to cause severe illness and death in otherwise healthy adults and children, despite the availability of low-cost, effective antibacterial therapy. Recognition early in the clinical course is critical because this is the period when antibacterial therapy is most effective. Early signs and symptoms of these illnesses are nonspecific or mimic other illnesses, which can make diagnosis challenging. This report updates the 2006 CDC recommendations on the diagnosis and management of tickborne rickettsial diseases in the United States and includes information on the practical aspects of epidemiology, clinical assessment, treatment, laboratory diagnosis, and prevention of tickborne rickettsial diseases.
Summary of Notifiable Infectious Diseases and Conditions
The official statistics, in tabular and graphic form, for the reported occurrence of nationally notifiable infectious diseases
Summary of Notifiable Noninfectious Conditions and Disease Outbreaks
The official statistics, in tabular and graphic form, for the reported occurrence of nationally notifiable noninfectious conditions and disease outbreaks in the United States.
- Page last reviewed: July 21, 2016
- Page last updated: July 21, 2016
- Content source: